A important advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://imogenagfz980333.hyperionwiki.com/2175161/revolutionary_introduction_tirzepatide_45mg_for_diabetes_control